Skip to Main Content

RxSight, Inc. Common Stock

RXST Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
RXST Income Statement
RXST Balance Sheet
RXST Cash Flow

Recent trades of RXST by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RXST Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
RXST Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RXST Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by RXST's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Light adjustable intraocular lens with a modulable absorption front protection layer Oct. 01, 2024
  • Patent Title: Light-adjustable lens illumination system with fovea protection Nov. 01, 2022
  • Patent Title: Light adjustable intraocular lens with a modulable absorption front protection layer Mar. 08, 2022
  • Patent Title: Blended extended depth of focus light adjustable lens with laterally offset axes Dec. 07, 2021
  • Patent Title: Birefringent intraocular lens Sep. 28, 2021
  • Patent Title: Intraocular lens inserter cartridge with an iol-guiding structure Aug. 10, 2021
  • Patent Title: Light adjustable lens tracking system and method May. 25, 2021
  • Patent Title: Composite light adjustable intraocular lens Apr. 06, 2021
  • Patent Title: Tracking-based illumination control system Mar. 02, 2021
  • Patent Title: Using the light adjustable lens (lal) to increase the depth of focus by inducing targeted amounts of asphericity Dec. 29, 2020
  • Patent Title: Intraocular lens visualization and tracking system Dec. 15, 2020
  • Patent Title: Adjustable optical elements with enhanced ultraviolet protection Nov. 12, 2019
  • Patent Title: Patient interface for light adjustable intraocular lens irradiation system Oct. 29, 2019
  • Patent Title: Depth of focus and visual acuity using colorized apodization of intra-ocular lenses Oct. 08, 2019
  • Patent Title: Method for modifying power of light adjustable lens Jan. 01, 2019
  • Patent Title: Using the light adjustable lens (lal) to increase the depth of focus by inducing targeted amounts of asphericity Jul. 03, 2018
  • Patent Title: Method for modifying power of light adjustable lens Apr. 24, 2018
  • Patent Title: Multilens intraocular system implantation with injectable accommodation material Feb. 06, 2018
  • Patent Title: Multilens intraocular lens system with injectable accommodation material Jul. 25, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of RXST in WallStreetBets Daily Discussion

RXST News

Recent insights relating to RXST

CNBC Recommendations

Recent picks made for RXST stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RXST

RXST Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RXST Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top